Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Zhou, H. Huang, Y. Wu, Y. Yan (Guangzhou, China). The relationships between PAC-1, CD62P and pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2007; 30: Suppl. 51, 498

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Platelet aggregation status in chronic obstructive pulmonary disease associated with SARS-Cov-19 Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Treatment of pulmonary hypertension in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313 Year: 2006 Pulmonary endothelial dysfunction in chronic obstructive pulmonary disease Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy Year: 2016 Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1 Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 612-617 Year: 2005 Effects of amlodipine on pulmonary haemodynamics in pulmonary hypertension (PH) secondary to chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002 Relationship between endothelial haemostatic markers in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Increased arterial stiffness in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 65s Year: 2006 Phenotypic characteristics of patients with arterial hypertension and chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Platelets count in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Pulmonary hypertension in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 892-905 Year: 2003 ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021